Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

Webinar: A scalable, cost-efficient method for targeted enrichment of long fragments for third-generation sequencing

Available on-demand

In this webinar, Andre Franke and Tim Steiert describe a scalable targeted enrichment protocol for fragment sizes of >7 kb. For demonstration purposes, they utilized a custom blood group panel of challenging loci. The test results demonstrate a highly multiplexed enrichment pool of 16 samples with this new protocol.



Platform-agnostic solutions for NGS.


Fill out the form below to register.

Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

Presenters

Andre Franke
Andre Franke

Professor, University of Kiel

Prof. Andre Franke (1978) is director of the Institute of Clinical Molecular Biology (IKMB) and leads the high-throughput laboratory facilities (biobank, sequencing and genotyping, and microbiome labs) as well as the bioinformatics unit of the Centre for Molecular Life Sciences (ZMB) at Kiel University.

Tim Steiert
Tim Steiert

PhD Student, University of Kiel

Tim Steiert is currently a PhD candidate at the Institute of Clinical Molecular Biology in Kiel. His research focuses on the optimization and development of techniques in the fields of second- and third-generation sequencing. Tim seeks to translate effective research approaches and develop affordable applications of sequencing in precision medicine for the benefit of patients.